4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000024
Chief Executive Officer sold 14,229 shares at an average $24.10 ($342,854)
- Chief Executive Officer returned 334,960 shares (to the company)
- Chief Executive Officer acquired 368,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric Chief Executive Officer | 2026-04-01 | Option exercise | +368,750 | $14.46 | $5,332,125 | 368,750 | D |
| Venker Eric Chief Executive Officer | 2026-04-01 | Returned to the company | −334,960 | $25.10 | $8,407,496 | 33,790 | D |
| Venker Eric Chief Executive Officer | 2026-04-02 | Sale | −12,820 | $24.04 | $308,193 | 20,970 | D |
| Venker Eric Chief Executive Officer | 2026-04-02 | Sale | −1,409 | $24.60 | $34,661 | 19,561 | D |
| Derivatives | |||||||
| Venker Eric Chief Executive Officer | 2026-04-01 | Option exercise · Capped Value Appreciation Rights | −368,750 | 1,106,250 | D | ||
| Open-market sales · 14,229 sh · avg $24.10 · $342,854 | |||||||
Loading xslF345X06/wk-form4_1775248378.xml…